Ligand validation:9DMC

DQV: [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl [(2R,3S,4R,5S)-5-(3-carbamoylphenyl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name)

DQV is a Ligand Of Interest in 9DMC designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9DMC_DQV_B_1101	88%	64%	0.097	0.972	0.59	0.79	-	1	0	0	100%	0.8
9DMC_DQV_A_1101	84%	65%	0.098	0.959	0.58	0.76	-	2	2	0	100%	1
9DMC_DQV_C_1101	82%	68%	0.1	0.954	0.61	0.62	-	1	1	0	100%	1
9DMC_DQV_D_1101	61%	67%	0.134	0.924	0.58	0.69	-	2	0	0	100%	0.85
9BPY_DQV_D_1101	85%	67%	0.066	0.929	0.59	0.69	-	1	0	0	100%	0.85
6BHV_DQV_D_1101	79%	64%	0.115	0.962	0.6	0.79	-	2	0	0	100%	1
6YGG_DQV_B_510	72%	2%	0.117	0.94	4.62	2.27	17	11	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.